Thursday, December 18, 2025 | 08:09 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

KKR-backed JB Chemicals scouts for acquisitions, plans to revamp business

With the former Cipla head at the helm, JB Chemicals now plans to diversify into paediatrics and respiratory

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
premium

JB Chemicals now wants to focus on cardio-metabolic disorders, a chronic portfolio, which has shown resilience even during the pandemic

Sohini Das New Delhi
KKR-backed JB Chemicals, the owner of marquee brands such as Rantac and Metrogyl, is scouting for acquisitions — of a portfolio of brands, or a company altogether. 

After the Mody family sold the company to private equity player KKR last year, the new management is trying to revamp the business. With the former Cipla head at the helm, JB Chemicals now plans to diversify into paediatrics and respiratory. 

Speaking to Business Standard, Nikhil Chopra, CEO and whole-time director of JB Chemicals, said: “We are looking for acquisitions — of a portfolio of brands or a small firm — that would